FDA MedWatch - SGLT2 (sodium-glucose cotransporter-2) Inhibitors for Diabetes: Drug Safety Communication - Regarding Rare Occurrences of a Serious Infection of the Genital Area
If your email program has trouble displaying this email, view it as a web page |
| ||||
U.S. Food and Drug Administration |
Comments
Post a Comment